When Patenting biotechnology becomes contra-productive to the aim of the Biotech Directive
Biotechnology has been regarded as the problem child of modern Patent Law for a long time. The legislation concerning biotechnology is in constant fluctuation, changing as the case law constantly develops. This leads up to uncertainty regarding what is to be considered as patentable, and what is not. Even today, no stable solution has been found. Furthermore, ethical concerns are given a place w